<p>STAAR Surgical（納斯達克股票代碼：STAA - 獲取免費報告）的股票在週三發佈的報告中被 Weiss Ratings 的股票研究分析師重新評定為 “賣出（d）” 評級，Weiss Ratings 報道。</p>
<p>獲取 <strong>STAAR Surgical</strong> 警報：</p>
<ul>
<li>內部人士顯著增持的四大股票</li>
</ul>
<p>STAA 已經成為其他多份報告的主題。Piper Sandler 在 6 月 18 日的報告中將 STAAR Surgical 的評級上調至 “持有”。Canaccord Genuity Group 在 8 月 6 日的研究報告中將 STAAR Surgical 的目標價格從 20.00 美元上調至 28.00 美元，並給予該公司 “持有” 評級。Mizuho 在 7 月 16 日的研究報告中將 STAAR Surgical 的目標價格從 17.00 美元上調至 18.00 美元，並給予該公司 “中性” 評級。最後，Stifel Nicolaus 在 8 月 7 日的研究報告中設定了 STAAR Surgical 的目標價格為 28.00 美元，並給予該公司 “持有” 評級。十位研究分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，STAAR Surgical 目前的共識評級為 “減持”，平均目標價格為 20.67 美元。</p>
<p><strong>查看我們對 STAAR Surgical 的最新分析</strong></p>
<h2>STAAR Surgical 股票下跌 0.8%</h2>
<ul>
<li>隨着 2024 年美國前景改善，Star Surgical 表現亮眼</li>
</ul>
<p>週三，STAA 的股價開盤為 26.50 美元。STAAR Surgical 的 12 個月低點為 13.50 美元，12 個月高點為 33.28 美元。該公司的 50 日移動平均線為 26.83 美元，200 日移動平均線為 20.79 美元。該股票的市值為 13.1 億美元，市盈率為-13.73，貝塔值為 0.82。</p>
<h2>機構投資者對 STAAR Surgical 的看法</h2>
<p>大型投資者最近增加或減少了對該公司的持股。CWM LLC 在第二季度將其在 STAAR Surgical 的持股增加了 74.1%。CWM LLC 現在擁有 1,563 股該醫療器械供應商的股票，價值 26,000 美元，此前在上個季度增持了 665 股。US Bancorp DE 在第一季度將其在 STAAR Surgical 的持股增加了 1,693.0%。US Bancorp DE 現在擁有 2,044 股該醫療器械供應商的股票，價值 36,000 美元，此前在上個季度增持了 1,930 股。Brooklyn Investment Group 在第一季度將其在 STAAR Surgical 的持股增加了 1,564.0%。Brooklyn Investment Group 現在擁有 2,679 股該醫療器械供應商的股票，價值 47,000 美元，此前在上個季度增持了 2,518 股。GAMMA Investing LLC 在第三季度將其在 STAAR Surgical 的持股增加了 61.4%。GAMMA Investing LLC 現在擁有 1,856 股該醫療器械供應商的股票，價值 50,000 美元，此前在上個季度增持了 706 股。最後，PNC Financial Services Group Inc.在第二季度將其在 STAAR Surgical 的持股增加了 691.0%。PNC Financial Services Group Inc.現在擁有 3,607 股該醫療器械供應商的股票，價值 61,000 美元，此前在上個季度增持了 3,151 股。對沖基金和其他機構投資者持有該公司 96.70% 的股票。</p>
<h2>關於 STAAR Surgical</h2>
<p>（獲取免費報告）</p>
<p>STAAR Surgical 公司及其子公司設計、開發、製造、營銷和銷售用於眼睛的植入式鏡片及其伴隨的輸送系統，以將鏡片送入眼睛。該公司提供植入式 Collamer 鏡片產品系列（ICLs），用於治療視覺障礙，如近視、遠視、散光和老花眼。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 STAAR Surgical</li>
<li>什麼是股息？購買最佳股息股票</li>
<li>Lowe’s 與 Home Depot：哪個更能從降低利率中受益？</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>這五隻被打壓的科技股可能會迎來反彈</li>
<li>投資便士股票需要了解什麼</li>
<li>Falcon Flex 推動增長，CrowdStrike 押注於 AI 安全</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 STAAR Surgical 嗎？</h2>
<p>在你考慮 STAAR Surgical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議現在購買，以便在更廣泛的市場注意到之前……而 STAAR Surgical 並不在名單上。</p>
<p>雖然 STAAR Surgical 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

達視光學

<p>Weiss Ratings 在最近的一份報告中 reaffirmed 對 STAAR Surgical (NASDAQ:STAA) 的 “賣出 (D)” 評級。該股票在其他分析師中獲得了混合評級，Piper Sandler 將其評級上調至 “持有”，Canaccord Genuity 將其目標價提高至 28.00 美元。目前，STAAR Surgical 的共識評級為 “減持”，平均目標價為 20.67 美元。該股票開盤價為 26.50 美元，市值為 13.1 億美元，市盈率為 -13.73。機構投資者持有該公司 96.70% 的股份</p>

<p>STAAR Surgical (NASDAQ:STAA - Get Free Report)'s stock had its &#34;sell (d)&#34; rating reissued by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.</p>
<div class="lb-trans"><p>STAAR Surgical（納斯達克股票代碼：STAA - 獲取免費報告）的股票在週三發佈的報告中被 Weiss Ratings 的股票研究分析師重新評定為 “賣出（d）” 評級，Weiss Ratings 報道。</p>
</div><p>Get <strong>STAAR Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>STAAR Surgical</strong> 警報：</p>
</div><ul>
<li>Top 4 Stocks With Notable Insider Buying</li>
</ul>
<div class="lb-trans"><ul>
<li>內部人士顯著增持的四大股票</li>
</ul>
</div><p>STAA has been the topic of a number of other reports. Piper Sandler upgraded STAAR Surgical to a &#34;hold&#34; rating in a report on Wednesday, June 18th. Canaccord Genuity Group raised their price objective on STAAR Surgical from $20.00 to $28.00 and gave the company a &#34;hold&#34; rating in a research note on Wednesday, August 6th. Mizuho raised their price objective on STAAR Surgical from $17.00 to $18.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, July 16th. Finally, Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a &#34;hold&#34; rating in a research note on Thursday, August 7th. Ten research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, STAAR Surgical presently has a consensus rating of &#34;Reduce&#34; and an average target price of $20.67.</p>
<div class="lb-trans"><p>STAA 已經成為其他多份報告的主題。Piper Sandler 在 6 月 18 日的報告中將 STAAR Surgical 的評級上調至 “持有”。Canaccord Genuity Group 在 8 月 6 日的研究報告中將 STAAR Surgical 的目標價格從 20.00 美元上調至 28.00 美元，並給予該公司 “持有” 評級。Mizuho 在 7 月 16 日的研究報告中將 STAAR Surgical 的目標價格從 17.00 美元上調至 18.00 美元，並給予該公司 “中性” 評級。最後，Stifel Nicolaus 在 8 月 7 日的研究報告中設定了 STAAR Surgical 的目標價格為 28.00 美元，並給予該公司 “持有” 評級。十位研究分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，STAAR Surgical 目前的共識評級為 “減持”，平均目標價格為 20.67 美元。</p>
</div><p><strong>View Our Latest Analysis on STAAR Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們對 STAAR Surgical 的最新分析</strong></p>
</div><h2>STAAR Surgical Stock Down 0.8%</h2>
<div class="lb-trans"><h2>STAAR Surgical 股票下跌 0.8%</h2>
</div><ul>
<li>Star Surgical Shines as U.S. Outlook Improves for 2024</li>
</ul>
<div class="lb-trans"><ul>
<li>隨着 2024 年美國前景改善，Star Surgical 表現亮眼</li>
</ul>
</div><p>Shares of STAA opened at $26.50 on Wednesday. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $33.28. The business's fifty day moving average is $26.83 and its 200 day moving average is $20.79. The stock has a market cap of $1.31 billion, a P/E ratio of -13.73 and a beta of 0.82.</p>
<div class="lb-trans"><p>週三，STAA 的股價開盤為 26.50 美元。STAAR Surgical 的 12 個月低點為 13.50 美元，12 個月高點為 33.28 美元。該公司的 50 日移動平均線為 26.83 美元，200 日移動平均線為 20.79 美元。該股票的市值為 13.1 億美元，市盈率為-13.73，貝塔值為 0.82。</p>
</div><h2>Institutional Investors Weigh In On STAAR Surgical</h2>
<div class="lb-trans"><h2>機構投資者對 STAAR Surgical 的看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. CWM LLC increased its holdings in STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 665 shares during the last quarter. US Bancorp DE increased its holdings in STAAR Surgical by 1,693.0% in the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 1,930 shares during the last quarter. Brooklyn Investment Group increased its holdings in STAAR Surgical by 1,564.0% in the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier's stock worth $47,000 after acquiring an additional 2,518 shares during the last quarter. GAMMA Investing LLC increased its holdings in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 706 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in STAAR Surgical by 691.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,607 shares of the medical instruments supplier's stock worth $61,000 after acquiring an additional 3,151 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company's stock.</p>
<div class="lb-trans"><p>大型投資者最近增加或減少了對該公司的持股。CWM LLC 在第二季度將其在 STAAR Surgical 的持股增加了 74.1%。CWM LLC 現在擁有 1,563 股該醫療器械供應商的股票，價值 26,000 美元，此前在上個季度增持了 665 股。US Bancorp DE 在第一季度將其在 STAAR Surgical 的持股增加了 1,693.0%。US Bancorp DE 現在擁有 2,044 股該醫療器械供應商的股票，價值 36,000 美元，此前在上個季度增持了 1,930 股。Brooklyn Investment Group 在第一季度將其在 STAAR Surgical 的持股增加了 1,564.0%。Brooklyn Investment Group 現在擁有 2,679 股該醫療器械供應商的股票，價值 47,000 美元，此前在上個季度增持了 2,518 股。GAMMA Investing LLC 在第三季度將其在 STAAR Surgical 的持股增加了 61.4%。GAMMA Investing LLC 現在擁有 1,856 股該醫療器械供應商的股票，價值 50,000 美元，此前在上個季度增持了 706 股。最後，PNC Financial Services Group Inc.在第二季度將其在 STAAR Surgical 的持股增加了 691.0%。PNC Financial Services Group Inc.現在擁有 3,607 股該醫療器械供應商的股票，價值 61,000 美元，此前在上個季度增持了 3,151 股。對沖基金和其他機構投資者持有該公司 96.70% 的股票。</p>
</div><h2>About STAAR Surgical</h2>
<div class="lb-trans"><h2>關於 STAAR Surgical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.</p>
<div class="lb-trans"><p>STAAR Surgical 公司及其子公司設計、開發、製造、營銷和銷售用於眼睛的植入式鏡片及其伴隨的輸送系統，以將鏡片送入眼睛。該公司提供植入式 Collamer 鏡片產品系列（ICLs），用於治療視覺障礙，如近視、遠視、散光和老花眼。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than STAAR Surgical</li>
<li>What Are Dividends? Buy the Best Dividend Stocks</li>
<li>Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>These 5 Beaten-Down Tech Stocks Could Catch Fire Next</li>
<li>What to Know About Investing in Penny Stocks</li>
<li>Falcon Flex Drives Growth as CrowdStrike Bets on AI Security</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 STAAR Surgical</li>
<li>什麼是股息？購買最佳股息股票</li>
<li>Lowe’s 與 Home Depot：哪個更能從降低利率中受益？</li>
<li>上海證券交易所綜合指數是什麼？</li>
<li>這五隻被打壓的科技股可能會迎來反彈</li>
<li>投資便士股票需要了解什麼</li>
<li>Falcon Flex 推動增長，CrowdStrike 押注於 AI 安全</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=STAA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in STAAR Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 STAAR Surgical 嗎？</h2>
</div><p>Before you consider STAAR Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 STAAR Surgical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STAAR Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議現在購買，以便在更廣泛的市場注意到之前……而 STAAR Surgical 並不在名單上。</p>
</div><p>While STAAR Surgical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 STAAR Surgical 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

達視光學（NASDAQ 代碼：STAA）被 Weiss Ratings 評為 “賣出（D）” 評級